EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
19.30
-0.26 (-1.33%)
Jul 31, 2026, 4:00 PM EDT - Market closed
EUDA Health Holdings Revenue
In the year 2025, EUDA Health Holdings had annual revenue of $6.82M with 70.04% growth. EUDA Health Holdings had revenue of $3.76M in the half year ending December 31, 2025.
Revenue (ttm)
$6.82M
Revenue Growth
+70.04%
P/S Ratio
8.47
Revenue / Employee
$55,449
Employees
123
Market Cap
57.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.82M | 2.81M | 70.04% |
| Dec 31, 2024 | 4.01M | 304.55K | 8.22% |
| Dec 31, 2023 | 3.71M | -57.84K | -1.54% |
| Dec 31, 2022 | 3.76M | -794.23K | -17.42% |
| Dec 31, 2021 | 4.56M | -4.32M | -48.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Douglas Elliman | 993.99M |
| Fathom Holdings | 413.74M |
| Altisource Portfolio Solutions | 182.50M |
| Star Holdings | 124.46M |
| Comstock Holding Companies | 67.67M |
| Fangdd Network Group | 50.73M |
| American Strategic Investment Co. | 38.32M |
| J.W. Mays | 21.43M |
EUDA News
- 3 days ago - EUDA Health enters collaboration for integrated iPSC cell therapy program - TheFly
- 3 days ago - EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products - GlobeNewsWire
- 5 days ago - EUDA Health signs MoU with GO POSB Organoids, SIIT - TheFly
- 5 days ago - EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies - GlobeNewsWire
- 18 days ago - EUDA Health Holdings Ltd trading resumes - TheFly
- 18 days ago - EUDA Health Holdings Ltd trading halted, volatility trading pause - TheFly
- 2 months ago - EUDA Health regains Nasdaq compliance - TheFly
- 2 months ago - EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask - GlobeNewsWire